IL1B and syndromic X-linked intellectual disability Lubs type: For these reasons, we would suggest that Anakinra-based treatments in individuals with MRXSL may ameliorate the symptoms mediated by an abnormal response to IL-1beta and possibly compensate to some extent for synaptic imbalance.